AzTrials
AzTrials

PrematurityNCT01645137

Effectiveness Of Osteopathic Manipulative Treatment In NICU: A Multicenter Clinical Trial

A study testing osteopathic manipulative treatment in people with Prematurity, run by European Institute for Evidence Based Osteopathic Medicine at 3 sites in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The use of complementary and alternative medicine in neonatal ward has been steadily rising during the last decade. This integrated medicine approach has been shown to be helpful to improve neonatal health care. Read more about this study

Who is it for?
Ages 29 to 37 weeksHealthy volunteers can take part
Conditions the study is for
Prematurity
What is being tested?
osteopathic manipulative treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
690 participants
Where
3 sitesItaly
Study dates
Jul 2012to Oct 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 29 to 37 weeks
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • preterm infants born at age between 29 and 37 weeks
  • osteopathic treatment performed < 14 days after birth
  • preterms born in the same hospital

Who cannot join

  • Gestational age < 29 weeks
  • Gestational age > 37 weeks
  • First OMT performed after 14 days from birth
  • genetic disorders
  • congenital disorders
  • cardiovascular abnormalities
Show all 15Show fewer
  • proven or suspected necrotized enterocolitis with or without gastrointestinal perforation
  • proven or suspected abdominal obstruction
  • pre/post surgery patients
  • pneumoperitoneum
  • atelectasis
  • Newborn from an HIV seropositive/drug addicted mother
  • respiratory disorders
  • transferred to/from other hospital
  • admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)

Trial locations and contacts

3 sites in 1 country.

Italy3 sites
  • Monza Hospital

    Monza, Lombardy, 20052

  • Pescara hospital

    Pescara, 65121

  • Macerata Hospital

    Province of Macerata, The Marches, 62100

Other trials in Italy

About this study

Official title: Effectiveness Of Osteopathic Manipulative Treatment In Neonatal Intensive Care Units: A Multicenter Randomized Clinical Trial

The use of complementary and alternative medicine in neonatal ward has been steadily rising during the last decade. This integrated medicine approach has been shown to be helpful to improve neonatal health care. Osteopathic manipulative treatment (OMT) has been applied to premature infants to reduce the length of stay and to cope with clinical complications. Results from previous studies documented the positive association between OMT and shorter period of hospitalisation as well as improvement of clinical conditions. The aim of this nationwide multicenter study is to demonstrate the effect of OMT on length of stay (LOS) in premature infants across 3 neonatal intensive care units (NICU).

Conditions
Prematurity
Being tested
osteopathic manipulative treatment, Usual care
Keywords
prematurity, OMT, complementary and alternative medicine, neonates, length of stay
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • osteopathic manipulative treatmentOther

    Patients from this group received osteopathic treatments twice a week for the entire length of stay in the unit.

  • Usual careOther

    Patients from control group received standard care plus osteopathic evaluation only, according to the same schedule as the study group.

Study groups in NCT01645137
Study groupRoleWhat they receive
OMTExperimentalpatients under usual medical care plus osteopathic treatment
Receives: Other: osteopathic manipulative treatment
controlOtherpatients under usual medical care
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of days of LOS

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

Secondary outcomes (6)
  1. pre-post difference in weight gain

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

  2. number of episodes of vomit

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

  3. days to full enteral feeding

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

  4. NICU costs

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

  5. number of episodes of regurgitation

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

  6. number of episodes of stooling

    Measured: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2012 (estimated)
  2. Study startJul 2012
  3. Primary completionSep 2013
  4. Study completionOct 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
690 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01645137
Sponsor's protocol ID
Multi-NE-O
Status last verified
Apr 2014
First submitted
15 Jul 2012
Last updated
25 Apr 2014
Results posted
No

Publications

  • Cerritelli F, Pizzolorusso G, Renzetti C, Cozzolino V, D'Orazio M, Lupacchini M, Marinelli B, Accorsi A, Lucci C, Lancellotti J, Ballabio S, Castelli C, Molteni D, Besana R, Tubaldi L, Perri FP, Fusilli P, D'Incecco C, Barlafante G. A multicenter, randomized, controlled trial of osteopathic manipulative treatment on preterms. PLoS One. 2015 May 14;10(5):e0127370. doi: 10.1371/journal.pone.0127370. eCollection 2015.

    PubMed 25974071
  • Cerritelli F, Pizzolorusso G, Renzetti C, D'Incecco C, Fusilli P, Perri PF, Tubaldi L, Barlafante G. Effectiveness of osteopathic manipulative treatment in neonatal intensive care units: protocol for a multicentre randomised clinical trial. BMJ Open. 2013 Feb 20;3(2):e002187. doi: 10.1136/bmjopen-2012-002187. Print 2013.

    PubMed 23430598

Questions about this trial

What is this clinical trial studying?

A study testing osteopathic manipulative treatment in people with Prematurity, run by European Institute for Evidence Based Osteopathic Medicine at 3 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of days of LOS (time frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01645137, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in